Skip to main content
. 2023 Aug 30;12(11):644–656. doi: 10.1089/wound.2021.0148

Table 2.

NOD-like receptor pyrin domain containing 3 inflammasome inhibitors currently not investigated in the context of diabetic wound healing

Inhibitor Mechanism Study Type Reference
Bot-4-one NACHT ATPase inhibitor In vitro, in vivo 77
CY-09 NACHT ATPase inhibitor: binds Walker A motif In vitro, in vivo 78
INF39 NACHT ATPase inhibitor In vitro, in vivo 79
MNS NACHT ATPase inhibitor In vitro, in vivo 80
OLT1177 NACHT ATPase inhibitor In vitro, in vivo, clinical 81
Oridonin Binds NLRP3 Cys279: inhibits NLRP3-NEK7 interaction In vitro, in vivo 82
Parthenolide NACHT ATPase inhibitor, caspase-1 inhibitor In vitro, in vivo 78

NEK7, NIMA-related kinase 7.